|
Volumn 42, Issue 4, 2010, Pages 1291-1293
|
Results With Cyclosporine Monotherapy in Long-Term Cardiac Transplant Recipients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
EVEROLIMUS;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DIALYSIS;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
FOLLOW UP;
GRAFT RECIPIENT;
HEART FAILURE;
HEART GRAFT;
HUMAN;
INFECTION;
MALE;
MALIGNANT NEOPLASTIC DISEASE;
MONOTHERAPY;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
SURVIVAL TIME;
ADRENAL CORTEX HORMONES;
ADULT;
AZATHIOPRINE;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
PATIENT SELECTION;
POSTOPERATIVE COMPLICATIONS;
SURVIVAL RATE;
SURVIVORS;
TIME FACTORS;
TISSUE DONORS;
|
EID: 77952562798
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2010.03.126 Document Type: Article |
Times cited : (5)
|
References (8)
|